Search This Blog

Wednesday, August 7, 2019

Allogene Therapeutics EPS beats by $0.04

Allogene Therapeutics (NASDAQ:ALLO): Q2 GAAP EPS of -$0.41 beats by $0.04.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)